NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Evelo Biosciences Inc (NASDAQ: EVLO)
EVLO Technical Analysis
5
As on 9th Jun 2023 EVLO STOCK Price closed @ 0.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.96 & Strong Sell for SHORT-TERM with Stoploss of 4.94 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EVLOSTOCK Price
Open | 0.11 | Change | Price | % |
High | 0.11 | 1 Day | -0.01 | -9.09 |
Low | 0.09 | 1 Week | -0.05 | -33.33 |
Close | 0.10 | 1 Month | 0.00 | 0.00 |
Volume | 4587469 | 1 Year | -7.52 | -98.69 |
52 Week High 8.00 | 52 Week Low 0.10 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
EVLO Daily Charts |
EVLO Intraday Charts |
Whats New @ Bazaartrend |
EVLO Free Analysis |
|
EVLO Important Levels Intraday
RESISTANCE | 0.14 |
RESISTANCE | 0.13 |
RESISTANCE | 0.12 |
RESISTANCE | 0.11 |
SUPPORT | 0.09 |
SUPPORT | 0.08 |
SUPPORT | 0.07 |
SUPPORT | 0.06 |
EVLO Forecast April 2024
4th UP Forecast | 5.13 |
3rd UP Forecast | 3.52 |
2nd UP Forecast | 2.52 |
1st UP Forecast | 1.52 |
1st DOWN Forecast | -1.32 |
2nd DOWN Forecast | -2.32 |
3rd DOWN Forecast | -3.32 |
4th DOWN Forecast | -4.93 |
EVLO Weekly Forecast
4th UP Forecast | 4.65 |
3rd UP Forecast | 3.19 |
2nd UP Forecast | 2.29 |
1st UP Forecast | 1.39 |
1st DOWN Forecast | -1.19 |
2nd DOWN Forecast | -2.09 |
3rd DOWN Forecast | -2.99 |
4th DOWN Forecast | -4.45 |
EVLO Forecast2024
4th UP Forecast | 15.94 |
3rd UP Forecast | 10.86 |
2nd UP Forecast | 7.72 |
1st UP Forecast | 4.58 |
1st DOWN Forecast | -4.38 |
2nd DOWN Forecast | -7.52 |
3rd DOWN Forecast | -10.66 |
4th DOWN Forecast | -15.74 |
Evelo Biosciences Inc ( NASDAQ USA Symbol : EVLO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
EVLO Other Details
Segment | EQ | |
Market Capital | 477380768.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
EVLO Address
EVLO Latest News
EVLO Business Profile
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in clinical development trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also engages in developing EDP1867, an inactivated investigational oral biologic for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. Address: 620 Memorial Drive, Cambridge, MA, United States, 02139
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service